{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T02:25:12Z","timestamp":1791080712608,"version":"4.1.0"},"reference-count":211,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.ejca.2013.03.016","type":"journal-article","created":{"date-parts":[[2013,5,16]],"date-time":"2013-05-16T02:57:24Z","timestamp":1368673044000},"page":"2331-2344","source":"Crossref","is-referenced-by-count":62,"title":["Ovarian cancer: Ion channel and aquaporin expression as novel targets of clinical potential"],"prefix":"10.1016","volume":"49","author":[{"given":"Julia","family":"Frede","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott P.","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fclten","family":"Oskay-\u00d6zcelik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeosun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Ioana Braicu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalid","family":"Sehouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Gabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa B.A.","family":"Djamgoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2013.03.016_b0005","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/j.ejca.2008.11.018","article-title":"EUROCARE-4. Survival of cancer patients diagnosed in 1995\u20131999. Results and commentary","volume":"45","author":"Sant","year":"2009","journal-title":"Eur J Cancer"},{"issue":"Suppl. 1","key":"10.1016\/j.ejca.2013.03.016_b0010","doi-asserted-by":"crossref","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","article-title":"Carcinoma of the ovary. FIGO 6th annual report on the results of treatment in gynecological cancer","volume":"95","author":"Heintz","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.ejca.2013.03.016_b0015","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1146\/annurev.pathol.4.110807.092246","article-title":"Ovarian cancer","volume":"4","author":"Cho","year":"2009","journal-title":"Annu Rev Pathol"},{"key":"10.1016\/j.ejca.2013.03.016_b0020","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jso.21288","article-title":"Intra-abdominal tumor dissemination pattern and surgical outcome in 214 patients with primary ovarian cancer","volume":"99","author":"Sehouli","year":"2009","journal-title":"J Surg Oncol"},{"key":"10.1016\/j.ejca.2013.03.016_b0025","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2009.09.017","article-title":"Epithelial-mesenchymal transition in ovarian cancer","volume":"291","author":"Vergara","year":"2010","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2013.03.016_b0030","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ygyno.2008.09.021","article-title":"Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer","volume":"112","author":"Fan","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2013.03.016_b0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2008.12.003","article-title":"Dissemination of intraperitoneal ovarian cancer: discussion of mechanisms and demonstration of lymphatic spreading in ovarian cancer model","volume":"72","author":"Feki","year":"2009","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.ejca.2013.03.016_b0040","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/IGC.0b013e3181a416d0","article-title":"Extra-abdominal metastases from epithelial ovarian carcinoma: an analysis of 20 cases","volume":"19","author":"Cheng","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejca.2013.03.016_b0045","first-page":"2793","article-title":"Brain metastases from epithelial ovarian cancer: overview and optimal management","volume":"29","author":"Pietzner","year":"2009","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nrc2644","article-title":"The biology of ovarian cancer: new opportunities for translation","volume":"9","author":"Bast","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2013.03.016_b0055","first-page":"263","article-title":"Prognostic factors in patients with stage I epithelial ovarian cancer","volume":"75","author":"Dembo","year":"1990","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ejca.2013.03.016_b0060","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"issue":"Suppl. 3","key":"10.1016\/j.ejca.2013.03.016_b0065","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1525-1438.2005.00441.x","article-title":"New tumor markers: CA125 and beyond","volume":"15","author":"Bast","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejca.2013.03.016_b0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1074\/mcp.R400006-MCP200","article-title":"Progress and challenges in screening for early detection of ovarian cancer","volume":"3","author":"Jacobs","year":"2004","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.ejca.2013.03.016_b0075","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1470-2045(09)70026-9","article-title":"Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)","volume":"10","author":"Menon","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2013.03.016_b0080","first-page":"1115","article-title":"Preoperative determination of CASA (Cancer Associated Serum Antigen) and CA-125 for the discrimination between benign and malignant pelvic tumor mass: a prospective study","volume":"23","author":"Sehouli","year":"2003","journal-title":"Anticancer Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0085","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1093\/jnci\/djp438","article-title":"Assessing lead time of selected ovarian cancer biomarkers: a nested case\u2013control study","volume":"102","author":"Anderson","year":"2010","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2013.03.016_b0090","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ygyno.2009.09.041","article-title":"Current state of biomarker development for clinical application in epithelial ovarian cancer","volume":"116","author":"Moore","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2013.03.016_b0095","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.clinbiochem.2009.10.012","article-title":"Nidogen-2: a new serum biomarker for ovarian cancer","volume":"43","author":"Kuk","year":"2010","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ejca.2013.03.016_b0100","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2009.05.022","article-title":"A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer","volume":"114","author":"Hu","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2013.03.016_b0105","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/1477-7819-10-174","article-title":"MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features","volume":"10","author":"Lee","year":"2012","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejca.2013.03.016_b0110","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrc2831","article-title":"Integrating high-throughput technologies in the quest for effective biomarkers for ovarian cancer","volume":"10","author":"Kulasingam","year":"2010","journal-title":"Nature Rev Cancer"},{"key":"10.1016\/j.ejca.2013.03.016_b0115","doi-asserted-by":"crossref","first-page":"4809","DOI":"10.1158\/0008-5472.CAN-10-0447","article-title":"Gene expression: protein interaction systems network modeling identifies transformation-associated molecules and pathways in ovarian cancer","volume":"70","author":"Bapat","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0120","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1158\/1940-6207.CAPR-10-0193","article-title":"A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer","volume":"4","author":"Zhu","year":"2011","journal-title":"Cancer Prev Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0125","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/CCO.0b013e32832eab1f","article-title":"Promising molecular targets in ovarian cancer","volume":"21","author":"Blagden","year":"2009","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.ejca.2013.03.016_b0130","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nrc3144","article-title":"Rethinking ovarian cancer: recommendations for improving outcomes","volume":"11","author":"Vaughan","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2013.03.016_b0135","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ejphar.2009.08.040","article-title":"Molecular pharmacology of voltage-gated sodium channel expression in metastatic disease: clinical potential of neonatal Nav1.5 in breast cancer","volume":"625","author":"Onkal","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ejca.2013.03.016_b0140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/1574892811308010066","article-title":"Persistent current blockers of voltage-gated sodium channels: a clinical opportunity for controlling metastatic disease","volume":"8","author":"Djamgoz","year":"2013","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10.1016\/j.ejca.2013.03.016_b0145","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.molmed.2010.01.005","article-title":"Ion channels and the hallmarks of cancer","volume":"16","author":"Prevarskaya","year":"2010","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.ejca.2013.03.016_b0150","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/embor.2008.75","article-title":"Ion channels: functional expression and therapeutic potential in cancer. Colloquium on Ion Channels and Cancer","volume":"9","author":"Fraser","year":"2008","journal-title":"EMBO Rep"},{"key":"10.1016\/j.ejca.2013.03.016_b1060","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1158\/0008-5472.CAN-12-4188","article-title":"Ion channels and transporters in cancer: pathophysiology, regulation and clinical potential","volume":"73","author":"Pedersen","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0160","doi-asserted-by":"crossref","first-page":"5381","DOI":"10.1158\/1078-0432.CCR-05-0327","article-title":"Voltage-gated sodium channel expression and potentiation of human breast cancer metastasis","volume":"11","author":"Fraser","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0165","first-page":"1213","article-title":"Expression and functional analysis of voltage-activated Na+ channels in human prostate cancer cell lines and their contribution to invasion in vitro","volume":"150","author":"Laniado","year":"1997","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejca.2013.03.016_b0170","doi-asserted-by":"crossref","first-page":"6957","DOI":"10.1158\/0008-5472.CAN-10-1169","article-title":"Voltage-gated Na+ channel SCN5A is a key regulator of a gene transcriptional network that controls colon cancer invasion","volume":"70","author":"House","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0175","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1093\/aje\/kwh103","article-title":"Aggregation of ovarian cancer with breast, ovarian, colorectal, and prostate cancer in first-degree relatives","volume":"159","author":"Tung","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ejca.2013.03.016_b0180","first-page":"96","article-title":"Different changes in transmembrane potential of cultured cells after ouabain-inhibited active Na+\/K+-transport","volume":"51","author":"Redmann","year":"1981","journal-title":"Arch Geschwulstforsch"},{"key":"10.1016\/j.ejca.2013.03.016_b0185","first-page":"125","article-title":"Effects of cytostatic drugs on the transmembrane potential and surface charge of cultured cells","volume":"51","author":"Walliser","year":"1981","journal-title":"Arch Geschwulstforsch"},{"key":"10.1016\/j.ejca.2013.03.016_b0190","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S1472-6483(10)60958-3","article-title":"Role of nerve growth factor and FSH receptor in epithelial ovarian cancer","volume":"11","author":"Bose","year":"2005","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.ejca.2013.03.016_b0195","doi-asserted-by":"crossref","first-page":"414676","DOI":"10.1155\/2010\/414676","article-title":"Targeting the EGF receptor for ovarian cancer therapy","volume":"2010","author":"Zeineldin","year":"2010","journal-title":"J Oncol"},{"key":"10.1016\/j.ejca.2013.03.016_b0200","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00424-003-1077-0","article-title":"Predominant expression of Kv1.3 voltage-gated K+ channel subunit in rat prostate cancer cell lines: electrophysiological, pharmacological and molecular characterisation","volume":"446","author":"Fraser","year":"2003","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.ejca.2013.03.016_b0205","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/MPA.0b013e3181a56ebf","article-title":"Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of Kv1.3 gene promoter methylation","volume":"38","author":"Brevet","year":"2009","journal-title":"Pancreas"},{"key":"10.1016\/j.ejca.2013.03.016_b0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/1476-4598-5-41","article-title":"Overexpression of Eag1 potassium channels in clinical tumours","volume":"5","author":"Hemmerlein","year":"2006","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ejca.2013.03.016_b0215","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/047002142X.ch17","article-title":"Expression and role of hERG channels in cancer cells","volume":"266","author":"Arcangeli","year":"2005","journal-title":"Novartis Found Symp"},{"key":"10.1016\/j.ejca.2013.03.016_b0220","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0014-2999(03)01825-9","article-title":"Effects of intermediate-conductance Ca2+-activated K+ channel modulators on human prostate cancer cell proliferation","volume":"471","author":"Parihar","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.ejca.2013.03.016_b0225","doi-asserted-by":"crossref","first-page":"C125","DOI":"10.1152\/ajpcell.00488.2003","article-title":"Functional and molecular identification of intermediate-conductance Ca2+-activated K+ channels in breast cancer cells: association with cell cycle progression","volume":"287","author":"Ouadid-Ahidouch","year":"2004","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ejca.2013.03.016_b0230","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00424-007-0258-7","article-title":"An intermediate-conductance Ca2+-activated K+ channel mediates B lymphoma cell cycle progression induced by serum","volume":"4546","author":"Wang","year":"2007","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.ejca.2013.03.016_b0235","doi-asserted-by":"crossref","first-page":"5107","DOI":"10.1038\/sj.onc.1210308","article-title":"Blockage of intermediate-conductance-Ca2+-activated K+ channels inhibits progression of human endometrial cancer","volume":"26","author":"Wang","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2013.03.016_b0240","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1038\/onc.2009.25","article-title":"Intermediate-conductance Ca2+-activated K+ channels (IKCa1) regulate human prostate cancer cell proliferation through a close control of calcium entry","volume":"28","author":"Lallet-Daher","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2013.03.016_b0245","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2407-4-93","article-title":"Expression of inwardly rectifying potassium channels (GIRKs) and beta-adrenergic regulation of breast cancer cell lines","volume":"4","author":"Plummer","year":"2004","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ejca.2013.03.016_b0250","first-page":"582","article-title":"Overexpression of the G-protein inwardly rectifying potassium channel 1 (GIRK1) in primary breast carcinomas correlates with axillary lymph node metastasis","volume":"61","author":"Stringer","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0255","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.bbrc.2008.01.014","article-title":"Expression of Kir4.1 in human astrocytic tumors: correlation with pathologic grade","volume":"367","author":"Tan","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejca.2013.03.016_b0260","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1535-6108(03)00054-0","article-title":"Genomic amplification and oncogenic properties of the KCNK9 potassium channel gene","volume":"3","author":"Mu","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejca.2013.03.016_b0265","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.bbrc.2004.02.041","article-title":"Cell-cycle-dependent expression of the large Ca2+-activated K+ channels in breast cancer cells","volume":"316","author":"Ouadid-Ahidouch","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejca.2013.03.016_b0270","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1469-7793.1998.093bz.x","article-title":"K+ channel block-induced mammalian neuroblastoma cell swelling: a possible mechanism to influence proliferation","volume":"510","author":"Rouzaire-Dubois","year":"1998","journal-title":"J Physiol"},{"key":"10.1016\/j.ejca.2013.03.016_b0275","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0024-3205(99)00218-0","article-title":"Activity of voltage-gated K+ channels is associated with cell proliferation and Ca2+ influx in carcinoma cells of colon cancer","volume":"65","author":"Yao","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.ejca.2013.03.016_b0280","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s002329900135","article-title":"Potassium channels, proliferation and G1 progression","volume":"154","author":"Wonderlin","year":"1996","journal-title":"J Membr Biol"},{"key":"10.1016\/j.ejca.2013.03.016_b0285","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s004410000216","article-title":"Cell volume regulation in immune cell apoptosis","volume":"301","author":"Gomez-Angelats","year":"2000","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0290","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1152\/physrev.1998.78.1.247","article-title":"Functional significance of cell volume regulatory mechanisms","volume":"78","author":"Lang","year":"1998","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ejca.2013.03.016_b0295","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.abb.2007.01.020","article-title":"Cell shrinkage and monovalent cation fluxes: role in apoptosis","volume":"462","author":"Bortner","year":"2007","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.ejca.2013.03.016_b0300","doi-asserted-by":"crossref","first-page":"7219","DOI":"10.1074\/jbc.M707809200","article-title":"Cationic gradient reversal and cytoskeleton-independent volume regulatory pathways define an early stage of apoptosis","volume":"283","author":"Bortner","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2013.03.016_b0305","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ygyno.2006.08.033","article-title":"Voltage-gated K+ channels are associated with cell proliferation and cell cycle of ovarian cancer cell","volume":"104","author":"Zhanping","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2013.03.016_b0310","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bbrc.2008.07.161","article-title":"The potassium ion channel opener NS1619 inhibits proliferation and induces apoptosis in A2780 ovarian cancer cells","volume":"375","author":"Han","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejca.2013.03.016_b0315","first-page":"2053","article-title":"Expression and activity of Kv1.3 potassium ion channels in human ovarian cancer cells","volume":"11","author":"ZhanPing","year":"2011","journal-title":"Prog Modern Biomed"},{"key":"10.1016\/j.ejca.2013.03.016_b0320","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1475-2867-11-6","article-title":"The role of Eag and HERG channels in cell proliferation and apoptotic cell death in SK-OV-3 ovarian cancer cell line","volume":"11","author":"Asher","year":"2011","journal-title":"Cancer Cell Int"},{"key":"10.1016\/j.ejca.2013.03.016_b0325","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.febslet.2012.04.007","article-title":"Suppression of cellular invasion by glibenclamide through inhibited secretion of platelet-derived growth factor in ovarian clear cell carcinoma ES-2 cells","volume":"586","author":"Yasukagawa","year":"2012","journal-title":"FEBS Lett"},{"key":"10.1016\/j.ejca.2013.03.016_b0330","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.3390\/s120505986","article-title":"Eag1 channels as potential cancer biomarkers","volume":"12","author":"Rodr\u00edguez-Rasgado","year":"2012","journal-title":"Sensors"},{"key":"10.1016\/j.ejca.2013.03.016_b0335","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1746-1596-5-78","article-title":"The Eag potassium channel as a new prognostic marker in ovarian cancer","volume":"5","author":"Asher","year":"2010","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.ejca.2013.03.016_b0340","doi-asserted-by":"crossref","first-page":"e41664","DOI":"10.1371\/journal.pone.0041664","article-title":"Role of KCNMA1 in Breast Cancer","volume":"7","author":"Oeggerli","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejca.2013.03.016_b0345","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s002329900066","article-title":"K+ channels and the intracellular calcium signal in human melanoma cell proliferation","volume":"151","author":"Lepple-Wienhues","year":"1996","journal-title":"J Membr Biol"},{"key":"10.1016\/j.ejca.2013.03.016_b0350","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1152\/physrev.00029.2001","article-title":"Molecular structure and physiological function of chloride channels","volume":"82","author":"Jentsch","year":"2002","journal-title":"Physiol Rev"},{"key":"10.1016\/j.ejca.2013.03.016_b0355","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1523\/JNEUROSCI.23-13-05572.2003","article-title":"Expression of voltage-gated chloride channels in human glioma cells","volume":"23","author":"Olsen","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.ejca.2013.03.016_b0360","doi-asserted-by":"crossref","first-page":"9205","DOI":"10.1523\/JNEUROSCI.1897-08.2008","article-title":"ClC3 is a critical regulator of the cell cycle in normal and malignant glial cells","volume":"28","author":"Habela","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.ejca.2013.03.016_b0365","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1159\/000100644","article-title":"Blockage of volume-activated chloride channels inhibits migration of nasopharyngeal carcinoma cells","volume":"19","author":"Mao","year":"2007","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.ejca.2013.03.016_b0370","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.bcp.2008.01.008","article-title":"Suppression of ClC-3 channel expression reduces migration of nasopharyngeal carcinoma cells","volume":"75","author":"Mao","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ejca.2013.03.016_b0375","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.bcp.2008.10.009","article-title":"Volume-activated chloride channels contribute to cell-cycle-dependent regulation of HeLa cell migration","volume":"77","author":"Mao","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ejca.2013.03.016_b0380","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1677\/erc.1.00898","article-title":"Alterations in the regulatory volume decrease (RVD) and swelling-activated Cl\u2212 current associated with neuroendocrine differentiation of prostate cancer epithelial cells","volume":"12","author":"Lemonnier","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.ejca.2013.03.016_b0385","doi-asserted-by":"crossref","first-page":"40510","DOI":"10.1074\/jbc.M104821200","article-title":"Tumor suppression by a proapoptotic calcium-activated chloride channel in mammary epithelium","volume":"276","author":"Elble","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2013.03.016_b0390","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1074\/jbc.M703758200","article-title":"Eag1 and Bestrophin 1 are up-regulated in fast-growing colonic cancer cells","volume":"283","author":"Spitzner","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2013.03.016_b0395","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1158\/0008-5472.CAN-12-0475-T","article-title":"TMEM16A induces MAPK and contributes directly to tumorigenesis and cancer progression","volume":"72","author":"Duvvuri","year":"2012","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0400","first-page":"267","article-title":"Cl-channel blockers inhibit cell proliferation and arrest the cell cycle of human ovarian cancer cells","volume":"29","author":"Li","year":"2008","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ejca.2013.03.016_b0405","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/IGC.0b013e3181a3d6d2","article-title":"Regulation of ovarian cancer cell adhesion and invasion by chloride channels","volume":"19","author":"Li","year":"2009","journal-title":"Int J Gynecol Cancer"},{"issue":"Suppl. 2","key":"10.1016\/j.ejca.2013.03.016_b0410","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF00878465","article-title":"Pharmacology of the potassium channel openers","volume":"9","author":"Edwards","year":"1995","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.ejca.2013.03.016_b0415","first-page":"543","article-title":"Effect of a chloride channel inhibitor, 5-nitro-2-(3-phenylpropylamino)-benzoate, on ovarian cancer cell migration","volume":"57","author":"Yu","year":"2011","journal-title":"Clin Lab"},{"key":"10.1016\/j.ejca.2013.03.016_b0420","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1021\/pr200603h","article-title":"A xenograft mouse model coupled with in-depth plasma proteome analysis facilitates identification of novel serum biomarkers for human ovarian cancer","volume":"11","author":"Tang","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0425","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.devcel.2011.11.008","article-title":"Rab25 and CLIC3 collaborate to promote integrin recycling from late endosomes\/lysosomes and drive cancer progression","volume":"22","author":"Dozynkiewicz","year":"2012","journal-title":"Dev Cell"},{"key":"10.1016\/j.ejca.2013.03.016_b0430","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1158\/1078-0432.CCR-06-1562","article-title":"Reciprocal modifications of CLIC4 in tumor epithelium and stroma mark malignant progression of multiple human cancers","volume":"13","author":"Suh","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0435","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1007\/s00418-008-0530-8","article-title":"The tumor microenvironment and its contribution to tumor evolution toward metastasis","volume":"130","author":"Lorusso","year":"2008","journal-title":"Histochem Cell Biol"},{"key":"10.1016\/j.ejca.2013.03.016_b0440","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.bbamcr.2008.11.010","article-title":"Molecular mechanisms of TRP regulation in tumor growth and metastasis","volume":"1793","author":"Gkika","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ejca.2013.03.016_b0445","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1097\/01.LAB.0000043910.41414.E7","article-title":"Calcium-selective ion channel, CaT1, is apically localized in gastrointestinal tract epithelia and is aberrantly expressed in human malignancies","volume":"82","author":"Zhuang","year":"2002","journal-title":"Lab Invest"},{"key":"10.1016\/j.ejca.2013.03.016_b0450","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1113\/jphysiol.2011.225862","article-title":"The role of the TRPV6 channel in cancer","volume":"590","author":"Lehen\u2019kyi","year":"2012","journal-title":"J Physiol"},{"key":"10.1016\/j.ejca.2013.03.016_b0455","doi-asserted-by":"crossref","first-page":"7858","DOI":"10.1038\/sj.onc.1206895","article-title":"Expression of the Ca2+-selective cation channel TRPV6 in human prostate cancer: a novel prognostic marker for tumor progression","volume":"22","author":"Fixemer","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2013.03.016_b0460","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.bbrc.2004.08.042","article-title":"TRPV6 and prostate cancer: cancer growth beyond the prostate correlates with increased TRPV6 Ca2+ channel expression","volume":"322","author":"Wissenbach","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejca.2013.03.016_b0465","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/onc.2008.475","article-title":"Transient receptor potential channel C3 contributes to the progression of human ovarian cancer","volume":"28","author":"Yang","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2013.03.016_b0470","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1073\/pnas.0509549102","article-title":"CaMKII and polo-like kinase 1 sequentially phosphorylate the cytostatic factor Emi2\/XErp1 to trigger its destruction and meiotic exit","volume":"103","author":"Hansen","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2013.03.016_b0475","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.cub.2005.07.030","article-title":"Calcium elevation at fertilization coordinates phosphorylation of XErp1\/Emi2 by Plx1 and CaMK II to release metaphase arrest by cytostatic factor","volume":"15","author":"Liu","year":"2005","journal-title":"Curr Biol"},{"key":"10.1016\/j.ejca.2013.03.016_b0480","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/366270a0","article-title":"Calmodulin-dependent protein kinase II mediates inactivation of MPF and CSF upon fertilization of Xenopus eggs","volume":"366","author":"Lorca","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2013.03.016_b0485","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1038\/nature04093","article-title":"Calcium triggers exit from meiosis II by targeting the APC\/C inhibitor XErp1 for degradation","volume":"437","author":"Rauh","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2013.03.016_b0490","doi-asserted-by":"crossref","first-page":"16759","DOI":"10.1016\/S0021-9258(19)84770-1","article-title":"Studies of the regulatory mechanism of Ca2+\/calmodulin-dependent protein kinase II. Mutation of threonine 286 to alanine and aspartate","volume":"264","author":"Fong","year":"1989","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2013.03.016_b0495","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/pros.1095","article-title":"Expression profiles of voltage-gated Na+ channel alpha-subunit genes in rat and human prostate cancer cell lines","volume":"48","author":"Diss","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.ejca.2013.03.016_b0500","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00232-005-0747-6","article-title":"Small-cell lung cancer (human): potentiation of endocytic membrane activity by voltage-gated Na+ channel expression in vitro","volume":"204","author":"Onganer","year":"2005","journal-title":"J Membr Biol"},{"key":"10.1016\/j.ejca.2013.03.016_b0505","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.biocel.2006.12.007","article-title":"Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines","volume":"39","author":"Roger","year":"2007","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ejca.2013.03.016_b0510","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.biocel.2005.12.003","article-title":"Human neoplastic mesothelial cells express voltage-gated sodium channels involved in cell motility","volume":"38","author":"Fulgenzi","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ejca.2013.03.016_b0515","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/jcp.20871","article-title":"Functional expression of voltage-gated sodium channels in primary cultures of human cervical cancer","volume":"210","author":"Diaz","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ejca.2013.03.016_b0520","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/carcin\/bgp220","article-title":"Epigenetics in cancer","volume":"31","author":"Sharma","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ejca.2013.03.016_b0525","doi-asserted-by":"crossref","first-page":"8085","DOI":"10.1038\/sj.onc.1205088","article-title":"Human embryonic genes re-expressed in cancer cells","volume":"20","author":"Monk","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2013.03.016_b0530","first-page":"1293","article-title":"Expression of voltage-gated sodium channel \u03b1 subunit in human ovarian cancer","volume":"23","author":"Gao","year":"2010","journal-title":"Oncol Rep"},{"key":"10.1016\/j.ejca.2013.03.016_b0535","first-page":"263","article-title":"Calcium signalling and tumorigenesis","volume":"2","author":"Rosado","year":"2004","journal-title":"Cancer Ther"},{"key":"10.1016\/j.ejca.2013.03.016_b0540","doi-asserted-by":"crossref","first-page":"18","DOI":"10.2174\/1574892811308010018","article-title":"Calcium channels and prostate cancer","volume":"8","author":"Shapovalov","year":"2013","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10.1016\/j.ejca.2013.03.016_b0545","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.canlet.2008.03.032","article-title":"Selective blockade of T-type Ca2+ channels suppresses human breast cancer cell proliferation","volume":"267","author":"Taylor","year":"2008","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2013.03.016_b0550","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/glia.20063","article-title":"Expression of T-type calcium channel splice variants in human glioma","volume":"48","author":"Latour","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.ejca.2013.03.016_b0555","first-page":"4535","article-title":"Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5\u2032CpG island in human tumors","volume":"59","author":"Toyota","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0560","first-page":"1002","article-title":"Inhibition of human prostate cancer proliferation in vitro and in a mouse model by a compound synthesized to block Ca2+ entry","volume":"60","author":"Haverstick","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0565","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1124\/mol.62.2.210","article-title":"The Ca(2+) channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms","volume":"62","author":"Bertolesi","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.ejca.2013.03.016_b0570","doi-asserted-by":"crossref","first-page":"10162","DOI":"10.1074\/jbc.M707159200","article-title":"CaV3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells","volume":"283","author":"Gackiere","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2013.03.016_b0575","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00232-005-0781-4","article-title":"Ion channels and cancer","volume":"205","author":"Kunzelmann","year":"2005","journal-title":"J Membr Biol"},{"key":"10.1016\/j.ejca.2013.03.016_b0580","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nrc2171","article-title":"Calcium and cancer: targeting Ca2+ transport","volume":"7","author":"Monteith","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2013.03.016_b0585","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/07357907.2011.568565","article-title":"Blockade of T-type Ca2+ channels inhibits human ovarian cancer cell proliferation","volume":"29","author":"Li","year":"2011","journal-title":"Cancer Invest"},{"key":"10.1016\/j.ejca.2013.03.016_b0590","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1677\/ERC-09-0152","article-title":"Gonadotropin-induced ovarian cancer cell migration and proliferation require extracellular signal-regulated kinase 1\/2 activation regulated by calcium and protein kinase C delta","volume":"17","author":"Mertens-Walker","year":"2010","journal-title":"Endocrine-Related Cancer"},{"key":"10.1016\/j.ejca.2013.03.016_b0595","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1146\/annurev-med-043010-193843","article-title":"Aquaporins: translating bench research to human disease","volume":"63","author":"Verkman","year":"2012","journal-title":"Ann Rev Med"},{"key":"10.1016\/j.ejca.2013.03.016_b0600","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1681\/ASN.2005080846","article-title":"Aquaporin-1 facilitates epithelial cell migration in kidney proximal tubule","volume":"17","author":"Hara-Chikuma","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.ejca.2013.03.016_b0605","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00109-007-0272-4","article-title":"Aquaporin-3 facilitates epidermal cell migration and proliferation during wound healing","volume":"86","author":"Hara-Chikuma","year":"2008","journal-title":"J Mol Med"},{"key":"10.1016\/j.ejca.2013.03.016_b0610","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1096\/fj.06-6848com","article-title":"Greatly impaired migration of implanted aquaporin-4-deficient astroglial cells in mouse brain toward a site of injury","volume":"21","author":"Auguste","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.ejca.2013.03.016_b0615","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1242\/jcs.02680","article-title":"Involvement of aquaporin-4 in astroglial cell migration and glial scar formation","volume":"118","author":"Saadoun","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.ejca.2013.03.016_b0620","first-page":"67","article-title":"Differential expression of aquaporin 5 and aquaporin 3 in squamous cell carcinoma and adenoid cystic carcinoma","volume":"41","author":"Ishimoto","year":"2012","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ejca.2013.03.016_b0625","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00404-011-1942-6","article-title":"Inhibitory effect of epigallocatechin gallate on ovarian cancer cell proliferation associated with aquaporin 5 expression","volume":"285","author":"Yan","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejca.2013.03.016_b0630","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00404-011-1908-8","article-title":"Proliferation inhibition of cisplatin and aquaporin 5 expression in human ovarian cancer cell CAOV3","volume":"285","author":"Yang","year":"2012","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ejca.2013.03.016_b0635","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s00280-007-0674-6","article-title":"Curcumin attenuates EGF-induced AQP3 up-regulation and cell migration in human ovarian cancer cells","volume":"62","author":"Ji","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ejca.2013.03.016_b0640","first-page":"1197","article-title":"Localisation and expression of aquaporin subtypes in epithelial ovarian tumours","volume":"26","author":"Yang","year":"2011","journal-title":"Histol Histopathol"},{"issue":"Suppl. 1","key":"10.1016\/j.ejca.2013.03.016_b0645","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1136\/ijgc-00009577-200602001-00074","article-title":"The influence of aquaporin-1 and microvessel density on ovarian carcinogenesis and ascites formation","volume":"16","author":"Yang","year":"2006","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ejca.2013.03.016_b0650","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ygyno.2005.08.054","article-title":"Expression and localization of aquaporin-5 in the epithelial ovarian tumors","volume":"100","author":"Yang","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2013.03.016_b0655","first-page":"1149","article-title":"Heterogeneous expression of the aquaporin 1 (AQP1) water channel in tumors of the prostate, breast, ovary, colon and lung: a study using high density multiple human tumor tissue microarrays","volume":"26","author":"Mobasheri","year":"2005","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ejca.2013.03.016_b0660","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s00249-004-0389-0","article-title":"Voltage-gated Na+ channels: multiplicity of expression, plasticity, functional implications and pathophysiological aspects","volume":"33","author":"Diss","year":"2004","journal-title":"Eur Biophys J"},{"key":"10.1016\/j.ejca.2013.03.016_b0665","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/(SICI)1097-4695(199810)37:1<60::AID-NEU5>3.0.CO;2-6","article-title":"Dynamic regulation of K+ channel gene expression in differentiated cells","volume":"37","author":"Levitan","year":"1998","journal-title":"J Neurobiol"},{"key":"10.1016\/j.ejca.2013.03.016_b0670","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.biocel.2009.01.016","article-title":"Protein\u2013protein interactions involving voltage-gated sodium channels: post-translational regulation, intracellular trafficking and functional expression","volume":"41","author":"Shao","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ejca.2013.03.016_b0675","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1289\/ehp.11297","article-title":"G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells","volume":"116","author":"Albanito","year":"2008","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.ejca.2013.03.016_b0680","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/sj.bjc.6605153","article-title":"Androgen-related expression of G-proteins in ovarian cancer","volume":"101","author":"Sheach","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2013.03.016_b0685","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1210\/mend.14.10.0532","article-title":"Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF","volume":"14","author":"Filardo","year":"2000","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ejca.2013.03.016_b0690","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1210\/mend.16.1.0758","article-title":"Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis","volume":"16","author":"Filardo","year":"2002","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.ejca.2013.03.016_b0695","doi-asserted-by":"crossref","first-page":"27008","DOI":"10.1074\/jbc.M403588200","article-title":"The G protein-coupled receptor GPR30 mediates c-fos up-regulation by 17beta-estradiol and phytoestrogens in breast cancer cells","volume":"279","author":"Maggiolini","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2013.03.016_b0700","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1126\/science.1106943","article-title":"A transmembrane intracellular estrogen receptor mediates rapid cell signaling","volume":"307","author":"Revankar","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.ejca.2013.03.016_b0705","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/jcp.22154","article-title":"Estrogen and non-genomic upregulation of voltage-gated Na+ channel activity in MDA-MB-231 human breast cancer cells: role in adhesion","volume":"224","author":"Fraser","year":"2010","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ejca.2013.03.016_b0710","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.ygyno.2006.07.007","article-title":"Nerve growth factor and its high-affinity receptor trkA participate in the control of vascular endothelial growth factor expression in epithelial ovarian cancer","volume":"104","author":"Campos","year":"2007","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2013.03.016_b0715","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3835(98)00119-0","article-title":"Influence of intratumoral basic fibroblast growth factor concentration on survival in ovarian cancer patients","volume":"130","author":"Obermair","year":"1998","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2013.03.016_b0720","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0303-7207(01)00709-2","article-title":"The prognostic value of metalloproteinases and angiogenic factors in ovarian carcinoma","volume":"187","author":"Davidson","year":"2002","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.ejca.2013.03.016_b0725","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1158\/1541-7786.MCR-08-0571","article-title":"Epidermal growth factor receptor-mediated membrane type 1 matrix metalloproteinase endocytosis regulates the transition between invasive versus expansive growth of ovarian carcinoma cells in three-dimensional collagen","volume":"7","author":"Moss","year":"2009","journal-title":"Mol Cancer Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0730","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1002\/jcp.20846","article-title":"Nerve growth factor enhances voltage-gated Na+ channel activity and Transwell migration in Mat-LyLu rat prostate cancer cell line","volume":"210","author":"Brackenbury","year":"2007","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ejca.2013.03.016_b0735","doi-asserted-by":"crossref","first-page":"13677","DOI":"10.1074\/jbc.275.18.13677","article-title":"Ras\/MEK\/ERK Up-regulation of the fibroblast KCa channel FIK is a common mechanism for basic fibroblast growth factor and transforming growth factor-beta suppression of myogenesis","volume":"275","author":"Pena","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2013.03.016_b0740","doi-asserted-by":"crossref","first-page":"L489","DOI":"10.1152\/ajplung.90282.2008","article-title":"EGF mediates calcium-activated chloride channel activation in the human bronchial epithelial cell line 16HBE14o-: involvement of tyrosine kinase p60c-src","volume":"295","author":"Jeulin","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ejca.2013.03.016_b0745","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1085\/jgp.200709775","article-title":"Acute downregulation of ENaC by EGF involves the PY motif and putative ERK phosphorylation site","volume":"130","author":"Falin","year":"2007","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.ejca.2013.03.016_b0750","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1093\/ndt\/gfm786","article-title":"Transforming growth factor-beta1 decreases epithelial sodium channel functionality in renal collecting duct cells via a Smad4-dependent pathway","volume":"23","author":"Chang","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.ejca.2013.03.016_b0755","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bbrc.2008.07.100","article-title":"Insulin-like growth factor-I inhibits rat arterial K(ATP) channels through PI3-kinase","volume":"374","author":"Hayabuchi","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejca.2013.03.016_b0760","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1038\/sj.bjc.6605381","article-title":"Activity of the multikinase inhibitor dasatinib against ovarian cancer cells","volume":"101","author":"Konecny","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2013.03.016_b0765","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/jcp.21289","article-title":"Epidermal growth factor upregulates motility of Mat-LyLu rat prostate cancer cells partially via voltage-gated Na+ channel activity","volume":"215","author":"Ding","year":"2008","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ejca.2013.03.016_b0770","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1476-4598-6-76","article-title":"Epidermal growth factor potentiates in vitro metastatic behaviour of human prostate cancer PC-3M cells: involvement of voltage-gated sodium channel","volume":"6","author":"Uysal-Onganer","year":"2007","journal-title":"Mol Cancer"},{"key":"10.1016\/j.ejca.2013.03.016_b0775","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/j.biocel.2006.06.014","article-title":"Docosahexaenoic acid (omega-3) blocks voltage-gated sodium channel activity and migration of MDA-MB-231 human breast cancer cells","volume":"38","author":"Isbilen","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ejca.2013.03.016_b0780","doi-asserted-by":"crossref","first-page":"7449","DOI":"10.1158\/0008-5472.CAN-09-1266","article-title":"Resveratrol suppresses growth of human ovarian cancer cells in culture and in a murine xenograft model: eukaryotic elongation factor 1A2 as a potential target","volume":"69","author":"Lee","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0785","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.7314\/APJCP.2012.13.4.1333","article-title":"Resveratrol exerts differential effects in vitro and in vivo against ovarian cancer cells","volume":"13","author":"Stakleff","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/j.ejca.2013.03.016_b0790","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/sj.bjp.0706897","article-title":"Inhibition of cardiac voltage-gated sodium channels by grape polyphenols","volume":"149","author":"Wallace","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ejca.2013.03.016_b0795","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0090-8258(03)00341-X","article-title":"Treatment of ovarian cancer: new strategies","volume":"90","author":"DiSaia","year":"2003","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2013.03.016_b0800","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/j.ajog.2004.05.025","article-title":"The epigenetics of ovarian cancer drug resistance and resensitization","volume":"191","author":"Balch","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ejca.2013.03.016_b0805","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3322\/canjclin.51.1.15","article-title":"Cancer statistics, 2001","volume":"51","author":"Greenlee","year":"2001","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.ejca.2013.03.016_b0810","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/nrc1123","article-title":"Ovarian cancer: strategies for overcoming resistance to chemotherapy","volume":"3","author":"Agarwal","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ejca.2013.03.016_b0815","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1093\/jnci\/92.16.1295","article-title":"A family of drug transporters: the multidrug resistance-associated proteins","volume":"92","author":"Borst","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2013.03.016_b0820","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1517\/17425255.2.3.351","article-title":"Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition","volume":"2","author":"Jedlitschky","year":"2006","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.ejca.2013.03.016_b0825","doi-asserted-by":"crossref","first-page":"N1","DOI":"10.1088\/0031-9155\/53\/2\/N01","article-title":"Dielectrophoretic analysis of changes in cytoplasmic ion levels due to ion channel blocker action reveals underlying differences between drug-sensitive and multidrug-resistant leukaemic cells","volume":"53","author":"Duncan","year":"2008","journal-title":"Phys Med Biol"},{"key":"10.1016\/j.ejca.2013.03.016_b0830","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1073\/pnas.85.6.2019","article-title":"Comparison of ion channels in multidrug-resistant and -sensitive human leukemic cells","volume":"85","author":"Lee","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2013.03.016_b0835","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.canlet.2005.07.032","article-title":"Membrane transporters and channels in chemo-resistance and -sensitivity of tumor cells","volume":"239","author":"Huang","year":"2006","journal-title":"Cancer Lett"},{"key":"10.1016\/j.ejca.2013.03.016_b0840","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.bbrc.2005.07.010","article-title":"Regulation of volume-sensitive Cl\u2212 channels in multi-drug resistant MCF7 cells","volume":"334","author":"Marin","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejca.2013.03.016_b0845","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/355830a0","article-title":"Volume-regulated chloride channels associated with the human multidrug-resistance P-glycoprotein","volume":"355","author":"Valverde","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ejca.2013.03.016_b0850","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0092-8674(92)90263-C","article-title":"Separation of drug transport and chloride channel functions of the human multidrug resistance P-glycoprotein","volume":"71","author":"Gill","year":"1992","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2013.03.016_b0855","first-page":"4156","article-title":"Inwardly rectifying K+ channels and volume-regulated anion channels in multidrug-resistant small cell lung cancer cells","volume":"53","author":"Jirsch","year":"1993","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0860","doi-asserted-by":"crossref","first-page":"31S","DOI":"10.1113\/jphysiol.1995.sp020562","article-title":"Volume-activated chloride currents associated with the multidrug resistance P-glycoprotein","volume":"482","author":"Higgins","year":"1995","journal-title":"J Physiol"},{"key":"10.1016\/j.ejca.2013.03.016_b0865","first-page":"5029","article-title":"Volume-activated chloride current is not related to P-glycoprotein overexpression","volume":"54","author":"Dong","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0870","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1085\/jgp.104.6.1129","article-title":"Swelling-activated chloride channels in multidrug-sensitive and -resistant cells","volume":"104","author":"Ehring","year":"1994","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.ejca.2013.03.016_b0875","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/jcp.1041610302","article-title":"Effects of P-glycoprotein expression on cyclic AMP and volume-activated ion fluxes and conductances in HT-29 colon adenocarcinoma cells","volume":"161","author":"Kunzelmann","year":"1994","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.ejca.2013.03.016_b0880","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/S0021-9258(17)42276-9","article-title":"Volume-sensitive chloride currents in four epithelial cell lines are not directly correlated to the expression of the MDR-1 gene","volume":"269","author":"Rasola","year":"1994","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ejca.2013.03.016_b0885","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1042\/bj3070713","article-title":"Volume-activated chloride currents are not correlated with P-glycoprotein expression","volume":"307","author":"De Greef","year":"1995","journal-title":"Biochem J"},{"key":"10.1016\/j.ejca.2013.03.016_b0890","doi-asserted-by":"crossref","first-page":"C14","DOI":"10.1152\/ajpcell.00654.2008","article-title":"Deregulation of apoptotic volume decrease and ionic movements in multidrug-resistant tumor cells: role of chloride channels","volume":"298","author":"Poulsen","year":"2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ejca.2013.03.016_b0895","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.bbrc.2008.06.070","article-title":"Pharmacologic blockade of chloride channel synergistically enhances apoptosis of chemotherapeutic drug-resistant cancer stem cells","volume":"373","author":"Kang","year":"2008","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejca.2013.03.016_b0900","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.toxlet.2009.11.018","article-title":"L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines","volume":"192","author":"Chiu","year":"2010","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.ejca.2013.03.016_b0905","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1124\/jpet.110.172809","article-title":"Tipifarnib-induced apoptosis in acute myeloid leukemia and multiple myeloma cells depends on Ca2+ influx through plasma membrane Ca2+ channels","volume":"337","author":"Yanamandra","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ejca.2013.03.016_b0910","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2174\/138161206775474503","article-title":"L-type calcium channels","volume":"12","author":"Triggle","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ejca.2013.03.016_b0915","first-page":"301","article-title":"Altered Ca2+-homeostasis of cisplatin-treated and low level resistant non-small-cell and small-cell lung cancer cells","volume":"31","author":"Schrodl","year":"2009","journal-title":"Cell Oncol"},{"key":"10.1016\/j.ejca.2013.03.016_b0920","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ijc.2910410220","article-title":"The reversal of doxorubicin resistance by verapamil is not due to an effect on calcium channels","volume":"41","author":"Huet","year":"1988","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2013.03.016_b0925","first-page":"184","article-title":"Verapamil-induced blockade of voltage-activated K+ current in small-cell lung cancer cells","volume":"257","author":"Pancrazio","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.ejca.2013.03.016_b0930","first-page":"69","article-title":"Influence of the multidrug transporter inhibitors on the activity of Kv1.3 voltage-gated potassium channels","volume":"60","author":"Teisseyre","year":"2009","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/j.ejca.2013.03.016_b0935","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1161\/01.CIR.0000155617.54749.09","article-title":"QTc prolongation by grapefruit juice and its potential pharmacological basis: HERG channel blockade by flavonoids","volume":"111","author":"Zitron","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ejca.2013.03.016_b0940","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s002320010041","article-title":"Verapamil block of large-conductance Ca-activated K channels in rat aortic myocytes","volume":"179","author":"Harper","year":"2001","journal-title":"J Membr Biol"},{"key":"10.1016\/j.ejca.2013.03.016_b0945","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.cellbi.2007.01.008","article-title":"Detection of potassium currents and regulation of multidrug resistance by potassium channels in human gastric cancer cells","volume":"31","author":"Han","year":"2007","journal-title":"Cell Biol Int"},{"key":"10.1016\/j.ejca.2013.03.016_b0950","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1242\/jeb.201.1.21","article-title":"Alterations of ionic membrane permeabilities in multidrug-resistant neuroblastoma\u00d7glioma hybrid cells","volume":"201","author":"G\u00e9rard","year":"1998","journal-title":"J Exp Biol"},{"key":"10.1016\/j.ejca.2013.03.016_b0955","first-page":"3736","article-title":"Enhancement of voltage-gated Na+ channel current associated with multidrug resistance in human leukemia cells","volume":"47","author":"Yamashita","year":"1987","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2013.03.016_b0960","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1177\/1073858408320293","article-title":"An emerging role for voltage-gated Na+ channels in cellular migration: regulation of central nervous system development and potentiation of invasive cancers","volume":"14","author":"Brackenbury","year":"2008","journal-title":"Neuroscientist"},{"key":"10.1016\/j.ejca.2013.03.016_b0965","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.tiv.2008.11.011","article-title":"Increased aquaglyceroporin 9 expression disrupts arsenic resistance in human lung cancer cells","volume":"23","author":"Miao","year":"2009","journal-title":"Toxicol In Vitro"},{"key":"10.1016\/j.ejca.2013.03.016_b0970","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.bbrc.2004.08.002","article-title":"Drug uptake and pharmacological modulation of drug sensitivity in leukemia by AQP9","volume":"322","author":"Bhattacharjee","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejca.2013.03.016_b0975","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1073\/pnas.0437994100","article-title":"Aquaglyceroporin AQP9: solute permeation and metabolic control of expression in liver","volume":"100","author":"Carbrey","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2013.03.016_b0980","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0304-4157(95)00013-5","article-title":"The role of the MDR protein in altered drug translocation across tumor cell membranes","volume":"1241","author":"Roepe","year":"1995","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ejca.2013.03.016_b0985","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/BF02110444","article-title":"Altered drug translocation mediated by the MDR protein: direct, indirect, or both?","volume":"28","author":"Roepe","year":"1996","journal-title":"J Bioenerg Biomembr"},{"key":"10.1016\/j.ejca.2013.03.016_b0990","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/jnci\/81.9.706","article-title":"Increased cytosolic pH in multidrug-resistant human lung tumor cells: effect of verapamil","volume":"81","author":"Keizer","year":"1989","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2013.03.016_b0995","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1085\/jgp.108.4.295","article-title":"Are altered pHi and membrane potential in hu MDR 1 transfectants sufficient to cause MDR protein-mediated multidrug resistance?","volume":"108","author":"Hoffman","year":"1996","journal-title":"J Gen Physiol"},{"key":"10.1016\/j.ejca.2013.03.016_b1000","doi-asserted-by":"crossref","first-page":"11154","DOI":"10.1073\/pnas.0603672103","article-title":"Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian inhibiting substance responsiveness","volume":"103","author":"Szotek","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejca.2013.03.016_b1005","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1007\/s12015-011-9344-5","article-title":"Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches","volume":"8","author":"Aguilar-Gallardo","year":"2012","journal-title":"Stem Cell Rev Reports"},{"key":"10.1016\/j.ejca.2013.03.016_b1010","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.yexcr.2009.04.017","article-title":"The role of hERG1 K+ channels and a functional link between hERG1 K+ channels and SDF-1 in acute leukemic cell migration","volume":"315","author":"Li","year":"2009","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ejca.2013.03.016_b1015","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.bbrc.2010.04.142","article-title":"High expression of large-conductance Ca2+-activated K+ channel in the CD133(+) subpopulation of SH-SY5Y neuroblastoma cells","volume":"396","author":"Park","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.ejca.2013.03.016_b1020","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2174\/1381612054546806","article-title":"Intracellular chloride channels: critical mediators of cell viability and potential targets for cancer therapy","volume":"11","author":"Suh","year":"2005","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ejca.2013.03.016_b1025","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s10555-006-9017-z","article-title":"Voltage-sensitive ion channels and cancer","volume":"25","author":"Fiske","year":"2006","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ejca.2013.03.016_b1030","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.2174\/138161206778522047","article-title":"Voltage-gated sodium channels: new targets in cancer therapy?","volume":"12","author":"Roger","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ejca.2013.03.016_b1035","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2174\/157489207782497244","article-title":"Voltage-gated ion channels, new targets in anti-cancer research","volume":"2","author":"Le Guennec","year":"2007","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"10.1016\/j.ejca.2013.03.016_b1040","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/nrd2983","article-title":"Voltage-gated potassium channels as therapeutic targets","volume":"8","author":"Wulff","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.ejca.2013.03.016_b1045","doi-asserted-by":"crossref","first-page":"5540","DOI":"10.1093\/emboj\/18.20.5540","article-title":"Oncogenic potential of EAG K(+) channels","volume":"18","author":"Pardo","year":"1999","journal-title":"EMBO J"},{"key":"10.1016\/j.ejca.2013.03.016_b1050","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ygyno.2008.11.032","article-title":"Multicellular spheroids in ovarian cancer metastases: biology and pathology","volume":"113","author":"Shield","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ejca.2013.03.016_b1055","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0002-9440(10)63708-X","article-title":"Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis","volume":"164","author":"Shih","year":"2004","journal-title":"Am J Pathol"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804913002190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804913002190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,10]],"date-time":"2024-05-10T20:13:58Z","timestamp":1715372038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804913002190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":211,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0959804913002190"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2013.03.016","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]}}}